General MedicationsORALGeneric
TAO
TROLEANDOMYCIN
Standard Dose
EQ 125MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview TAO is listed in Drugs@FDA under application 050332 (NDA).
Marketing status: Discontinued Active ingredient TROLEANDOMYCIN Form and strength SUSPENSION;ORAL - EQ 125MG BASE/5ML Sponsor PFIZER Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview TAO is listed in Drugs@FDA under application 050332 (NDA). Marketing status: Discontinued Active ingredient TROLEANDOMYCIN Form and strength SUSPENSION;ORAL - EQ 125MG BASE/5ML Sponsor PFIZER Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.